Structural, Functional, and Clinical Characterization of a Novel PTPN11 Mutation Cluster Underlying Noonan Syndrome

Luca Pannone, Gianfranco Bocchinfuso, Elisabetta Flex, Cesare Rossi, Giuseppina Baldassarre, Christina Lissewski, Francesca Pantaleoni, Federica Consoli, Francesca Lepri, Monia Magliozzi, Massimiliano Anselmi, Silvia Delle Vigne, Giovanni Sorge, Kadri Karaer, Goran Cuturilo, Alessandro Sartorio, Sigrid Tinschert, Maria Accadia, Maria C. Digilio, Giuseppe ZampinoAlessandro De Luca, Hélène Cavé, Martin Zenker, Bruce D. Gelb, Bruno Dallapiccola, Lorenzo Stella, Giovanni B. Ferrero, Simone Martinelli, Marco Tartaglia

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Germline mutations in PTPN11, the gene encoding the Src-homology 2 (SH2) domain-containing protein tyrosine phosphatase (SHP2), cause Noonan syndrome (NS), a relatively common, clinically variable, multisystem disorder. Here, we report on the identification of five different PTPN11 missense changes affecting residues Leu261, Leu262, and Arg265 in 16 unrelated individuals with clinical diagnosis of NS or with features suggestive for this disorder, specifying a novel disease-causing mutation cluster. Expression of the mutant proteins in HEK293T cells documented their activating role on MAPK signaling. Structural data predicted a gain-of-function role of substitutions at residues Leu262 and Arg265 exerted by disruption of the N-SH2/PTP autoinhibitory interaction. Molecular dynamics simulations suggested a more complex behavior for changes affecting Leu261, with possible impact on SHP2's catalytic activity/selectivity and proper interaction of the PTP domain with the regulatory SH2 domains. Consistent with that, biochemical data indicated that substitutions at codons 262 and 265 increased the catalytic activity of the phosphatase, while those affecting codon 261 were only moderately activating but impacted substrate specificity. Remarkably, these mutations underlie a relatively mild form of NS characterized by low prevalence of cardiac defects, short stature, and cognitive and behavioral issues, as well as less evident typical facial features.

Original languageEnglish
Pages (from-to)451-459
Number of pages9
JournalHuman Mutation
Volume38
Issue number4
DOIs
Publication statusPublished - Apr 1 2017

Fingerprint

Noonan Syndrome
Codon
Mutation
SH2 Domain-Containing Protein Tyrosine Phosphatases
Protein Tyrosine Phosphatases
src Homology Domains
Germ-Line Mutation
Mutant Proteins
Molecular Dynamics Simulation
Substrate Specificity
Phosphoric Monoester Hydrolases
Genes

Keywords

  • genotype-phenotype correlation analysis
  • Noonan syndrome
  • PTPN11 mutations
  • structural and functional studies

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Structural, Functional, and Clinical Characterization of a Novel PTPN11 Mutation Cluster Underlying Noonan Syndrome. / Pannone, Luca; Bocchinfuso, Gianfranco; Flex, Elisabetta; Rossi, Cesare; Baldassarre, Giuseppina; Lissewski, Christina; Pantaleoni, Francesca; Consoli, Federica; Lepri, Francesca; Magliozzi, Monia; Anselmi, Massimiliano; Delle Vigne, Silvia; Sorge, Giovanni; Karaer, Kadri; Cuturilo, Goran; Sartorio, Alessandro; Tinschert, Sigrid; Accadia, Maria; Digilio, Maria C.; Zampino, Giuseppe; De Luca, Alessandro; Cavé, Hélène; Zenker, Martin; Gelb, Bruce D.; Dallapiccola, Bruno; Stella, Lorenzo; Ferrero, Giovanni B.; Martinelli, Simone; Tartaglia, Marco.

In: Human Mutation, Vol. 38, No. 4, 01.04.2017, p. 451-459.

Research output: Contribution to journalArticle

Pannone, L, Bocchinfuso, G, Flex, E, Rossi, C, Baldassarre, G, Lissewski, C, Pantaleoni, F, Consoli, F, Lepri, F, Magliozzi, M, Anselmi, M, Delle Vigne, S, Sorge, G, Karaer, K, Cuturilo, G, Sartorio, A, Tinschert, S, Accadia, M, Digilio, MC, Zampino, G, De Luca, A, Cavé, H, Zenker, M, Gelb, BD, Dallapiccola, B, Stella, L, Ferrero, GB, Martinelli, S & Tartaglia, M 2017, 'Structural, Functional, and Clinical Characterization of a Novel PTPN11 Mutation Cluster Underlying Noonan Syndrome', Human Mutation, vol. 38, no. 4, pp. 451-459. https://doi.org/10.1002/humu.23175
Pannone, Luca ; Bocchinfuso, Gianfranco ; Flex, Elisabetta ; Rossi, Cesare ; Baldassarre, Giuseppina ; Lissewski, Christina ; Pantaleoni, Francesca ; Consoli, Federica ; Lepri, Francesca ; Magliozzi, Monia ; Anselmi, Massimiliano ; Delle Vigne, Silvia ; Sorge, Giovanni ; Karaer, Kadri ; Cuturilo, Goran ; Sartorio, Alessandro ; Tinschert, Sigrid ; Accadia, Maria ; Digilio, Maria C. ; Zampino, Giuseppe ; De Luca, Alessandro ; Cavé, Hélène ; Zenker, Martin ; Gelb, Bruce D. ; Dallapiccola, Bruno ; Stella, Lorenzo ; Ferrero, Giovanni B. ; Martinelli, Simone ; Tartaglia, Marco. / Structural, Functional, and Clinical Characterization of a Novel PTPN11 Mutation Cluster Underlying Noonan Syndrome. In: Human Mutation. 2017 ; Vol. 38, No. 4. pp. 451-459.
@article{ac186417a3574a589bdee9b6fa678ae9,
title = "Structural, Functional, and Clinical Characterization of a Novel PTPN11 Mutation Cluster Underlying Noonan Syndrome",
abstract = "Germline mutations in PTPN11, the gene encoding the Src-homology 2 (SH2) domain-containing protein tyrosine phosphatase (SHP2), cause Noonan syndrome (NS), a relatively common, clinically variable, multisystem disorder. Here, we report on the identification of five different PTPN11 missense changes affecting residues Leu261, Leu262, and Arg265 in 16 unrelated individuals with clinical diagnosis of NS or with features suggestive for this disorder, specifying a novel disease-causing mutation cluster. Expression of the mutant proteins in HEK293T cells documented their activating role on MAPK signaling. Structural data predicted a gain-of-function role of substitutions at residues Leu262 and Arg265 exerted by disruption of the N-SH2/PTP autoinhibitory interaction. Molecular dynamics simulations suggested a more complex behavior for changes affecting Leu261, with possible impact on SHP2's catalytic activity/selectivity and proper interaction of the PTP domain with the regulatory SH2 domains. Consistent with that, biochemical data indicated that substitutions at codons 262 and 265 increased the catalytic activity of the phosphatase, while those affecting codon 261 were only moderately activating but impacted substrate specificity. Remarkably, these mutations underlie a relatively mild form of NS characterized by low prevalence of cardiac defects, short stature, and cognitive and behavioral issues, as well as less evident typical facial features.",
keywords = "genotype-phenotype correlation analysis, Noonan syndrome, PTPN11 mutations, structural and functional studies",
author = "Luca Pannone and Gianfranco Bocchinfuso and Elisabetta Flex and Cesare Rossi and Giuseppina Baldassarre and Christina Lissewski and Francesca Pantaleoni and Federica Consoli and Francesca Lepri and Monia Magliozzi and Massimiliano Anselmi and {Delle Vigne}, Silvia and Giovanni Sorge and Kadri Karaer and Goran Cuturilo and Alessandro Sartorio and Sigrid Tinschert and Maria Accadia and Digilio, {Maria C.} and Giuseppe Zampino and {De Luca}, Alessandro and H{\'e}l{\`e}ne Cav{\'e} and Martin Zenker and Gelb, {Bruce D.} and Bruno Dallapiccola and Lorenzo Stella and Ferrero, {Giovanni B.} and Simone Martinelli and Marco Tartaglia",
year = "2017",
month = "4",
day = "1",
doi = "10.1002/humu.23175",
language = "English",
volume = "38",
pages = "451--459",
journal = "Human Mutation",
issn = "1059-7794",
publisher = "John Wiley and Sons Inc.",
number = "4",

}

TY - JOUR

T1 - Structural, Functional, and Clinical Characterization of a Novel PTPN11 Mutation Cluster Underlying Noonan Syndrome

AU - Pannone, Luca

AU - Bocchinfuso, Gianfranco

AU - Flex, Elisabetta

AU - Rossi, Cesare

AU - Baldassarre, Giuseppina

AU - Lissewski, Christina

AU - Pantaleoni, Francesca

AU - Consoli, Federica

AU - Lepri, Francesca

AU - Magliozzi, Monia

AU - Anselmi, Massimiliano

AU - Delle Vigne, Silvia

AU - Sorge, Giovanni

AU - Karaer, Kadri

AU - Cuturilo, Goran

AU - Sartorio, Alessandro

AU - Tinschert, Sigrid

AU - Accadia, Maria

AU - Digilio, Maria C.

AU - Zampino, Giuseppe

AU - De Luca, Alessandro

AU - Cavé, Hélène

AU - Zenker, Martin

AU - Gelb, Bruce D.

AU - Dallapiccola, Bruno

AU - Stella, Lorenzo

AU - Ferrero, Giovanni B.

AU - Martinelli, Simone

AU - Tartaglia, Marco

PY - 2017/4/1

Y1 - 2017/4/1

N2 - Germline mutations in PTPN11, the gene encoding the Src-homology 2 (SH2) domain-containing protein tyrosine phosphatase (SHP2), cause Noonan syndrome (NS), a relatively common, clinically variable, multisystem disorder. Here, we report on the identification of five different PTPN11 missense changes affecting residues Leu261, Leu262, and Arg265 in 16 unrelated individuals with clinical diagnosis of NS or with features suggestive for this disorder, specifying a novel disease-causing mutation cluster. Expression of the mutant proteins in HEK293T cells documented their activating role on MAPK signaling. Structural data predicted a gain-of-function role of substitutions at residues Leu262 and Arg265 exerted by disruption of the N-SH2/PTP autoinhibitory interaction. Molecular dynamics simulations suggested a more complex behavior for changes affecting Leu261, with possible impact on SHP2's catalytic activity/selectivity and proper interaction of the PTP domain with the regulatory SH2 domains. Consistent with that, biochemical data indicated that substitutions at codons 262 and 265 increased the catalytic activity of the phosphatase, while those affecting codon 261 were only moderately activating but impacted substrate specificity. Remarkably, these mutations underlie a relatively mild form of NS characterized by low prevalence of cardiac defects, short stature, and cognitive and behavioral issues, as well as less evident typical facial features.

AB - Germline mutations in PTPN11, the gene encoding the Src-homology 2 (SH2) domain-containing protein tyrosine phosphatase (SHP2), cause Noonan syndrome (NS), a relatively common, clinically variable, multisystem disorder. Here, we report on the identification of five different PTPN11 missense changes affecting residues Leu261, Leu262, and Arg265 in 16 unrelated individuals with clinical diagnosis of NS or with features suggestive for this disorder, specifying a novel disease-causing mutation cluster. Expression of the mutant proteins in HEK293T cells documented their activating role on MAPK signaling. Structural data predicted a gain-of-function role of substitutions at residues Leu262 and Arg265 exerted by disruption of the N-SH2/PTP autoinhibitory interaction. Molecular dynamics simulations suggested a more complex behavior for changes affecting Leu261, with possible impact on SHP2's catalytic activity/selectivity and proper interaction of the PTP domain with the regulatory SH2 domains. Consistent with that, biochemical data indicated that substitutions at codons 262 and 265 increased the catalytic activity of the phosphatase, while those affecting codon 261 were only moderately activating but impacted substrate specificity. Remarkably, these mutations underlie a relatively mild form of NS characterized by low prevalence of cardiac defects, short stature, and cognitive and behavioral issues, as well as less evident typical facial features.

KW - genotype-phenotype correlation analysis

KW - Noonan syndrome

KW - PTPN11 mutations

KW - structural and functional studies

UR - http://www.scopus.com/inward/record.url?scp=85012045855&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85012045855&partnerID=8YFLogxK

U2 - 10.1002/humu.23175

DO - 10.1002/humu.23175

M3 - Article

AN - SCOPUS:85012045855

VL - 38

SP - 451

EP - 459

JO - Human Mutation

JF - Human Mutation

SN - 1059-7794

IS - 4

ER -